Working up a child with demyelinating optic neuritis: Striking a balance!

Virender Sachdeva1, Ramesh Kekunnaya2

  • 1Nimmagadda Prasad Childrenfs Eye Care Centre, Child Sight Institute, Department of Pediatric Ophthalmology, Strabismus and Neuro-Ophthalmology, L V Prasad Eye Institute, Visakhapatnam, Andhra Pradesh, India.

Insights

Pediatric optic neuritis (PON) evaluation can be streamlined. This review proposes a balanced approach using clinical features and neuroimaging, supported by serological tests for accurate diagnosis of childhood vision loss.

Area of Science:

  • Pediatric Neurology
  • Ophthalmology
  • Neuroimmunology

Background:

  • Pediatric optic neuritis (PON) is a leading cause of acute vision loss in children.
  • PON can be the initial symptom of various neuroinflammatory disorders, including multiple sclerosis and neuromyelitis optica spectrum disorder.
  • Current diagnostic workups involve extensive and costly tests like neuroimaging, serology, and cerebrospinal fluid analysis.

Purpose of the Study:

  • To propose a balanced and cost-effective approach for evaluating pediatric optic neuritis.
  • To guide clinicians in diagnosing the underlying etiology of PON based on recent literature.
  • To differentiate between infectious/postvaccination causes and primary neuroinflammatory conditions.

Main Methods:

  • Review of recent literature (last decade) on pediatric optic neuritis diagnosis.
  • Analysis of the diagnostic utility of clinical features and neuroimaging.
  • Evaluation of the role of serological tests in confirming specific neuroinflammatory syndromes.

Main Results:

  • Neuroimaging and specific clinical findings can suggest the underlying cause of PON.
  • Serological tests are crucial for confirming diagnoses like myelin oligodendrocyte glycoprotein associated optic neuritis.
  • A tiered diagnostic approach can optimize resource utilization.

Conclusions:

  • A balanced diagnostic strategy for PON is feasible and necessary, especially in resource-limited settings.
  • Integrating clinical assessment, neuroimaging, and targeted serological testing improves diagnostic accuracy.
  • This approach aids in early identification and management of serious neuroinflammatory conditions in children.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
771
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
899
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1000
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.2K